These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3555327)

  • 41. Therapeutic implications of the intestinal microflora.
    Goldman P
    N Engl J Med; 1973 Sep; 289(12):623-8. PubMed ID: 4146730
    [No Abstract]   [Full Text] [Related]  

  • 42. [Digestive lesions in acute intestinal infections].
    Cerf M
    Ann Gastroenterol Hepatol (Paris); 1992; 28(6-7):267. PubMed ID: 1285635
    [No Abstract]   [Full Text] [Related]  

  • 43. [Experimental dysbacteriosis in gnotobiotic chicks].
    Moskalik RS; Nikolaeva AV; Timoshko MA
    Veterinariia; 1979 Jul; (7):38-41. PubMed ID: 232329
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effect of enterococci on normalizing the intestinal microflora in experimental dysbacteriosis].
    Korshunov VM; Logadyr' TA; Popova SN; Tulina SG
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Sep; (9):3-6. PubMed ID: 2588877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro biotransformation of red ginseng extract by human intestinal microflora: metabolites identification and metabolic profile elucidation using LC-Q-TOF/MS.
    Wang HY; Hua HY; Liu XY; Liu JH; Yu BY
    J Pharm Biomed Anal; 2014 Sep; 98():296-306. PubMed ID: 24973593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Composition of intestinal microflora in various kidney diseases].
    Karpov PF; Seniuk VF; Tatarinova VV; Sushko SF; Koshel' LF
    Vrach Delo; 1989 Feb; (2):8-11. PubMed ID: 2711677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dysbacteriosis--infectious processes of mixed etiology].
    Smolianskaia AZ
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):186-90. PubMed ID: 3555326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intestinal dysbacteriosis: current aspects of studying the problem, principles of diagnosis and treatment].
    Ardatskaia MD; Dubinin AV; Minushkin ON
    Ter Arkh; 2001; 73(2):67-72. PubMed ID: 11338863
    [No Abstract]   [Full Text] [Related]  

  • 49. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
    Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM
    Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Microecological disorders in the intestines of patients with chronic kidney failure and the arterial hypertension syndrome].
    Bobrov VA; Karpov PF
    Ter Arkh; 1993; 65(6):41-3. PubMed ID: 8378848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New experimental models in microbial ecology].
    Liz'ko NN
    Antibiot Khimioter; 1989 Jun; 34(6):443-8. PubMed ID: 2802876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Humoral and cellular immunologic tests in the evaluation of dysbacteriosis in acute intestinal diseases].
    Nuromskaia OA; Datsenko MF; Poguda AA; Koval'chuk AN; Taran LD
    Vrach Delo; 1984 Jan; (1):117-8. PubMed ID: 6702155
    [No Abstract]   [Full Text] [Related]  

  • 53. [The characterization of the intestinal microflora in patients with extrahospital pneumonia].
    Osipov MIu; Bilev AE; Osipov IuA
    Klin Med (Mosk); 2007; 85(9):67-71. PubMed ID: 18038574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the intestinal microflora in clonazepam metabolism in the rat.
    Elmer GW; Remmel RP
    Xenobiotica; 1984 Nov; 14(11):829-40. PubMed ID: 6506755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Microfloral changes in the small and large intestines of chronic enteritis patients on diet therapy including sour milk products].
    Sukhov SV; Kalamkarova LI; Il'chenko LA; Zhangabylov AK
    Vopr Pitan; 1986; (4):14-7. PubMed ID: 3765530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Increased antibody titers to bifidobacteria as a marker of intestinal dysbacteriosis].
    Anikhovskaia IA; Vyshegurov IaKh; Likhoded VG; Iakovlev MIu
    Fiziol Cheloveka; 2005; 31(2):132-4. PubMed ID: 15889831
    [No Abstract]   [Full Text] [Related]  

  • 57. [Intestinal and skin microflora changes in acute leukemia patients during decontamination].
    Nasonova TA; Mal'tsev VN; Smirnova OV; Isichenko IB; Reshchikova EV
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):24-8. PubMed ID: 7279891
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of intestinal microflora on the enterohepatic circulation of mercapturic acid pathway metabolites.
    Gustafsson JA; Rafter JJ; Bakke JE; Gustafsson BE
    Nutr Cancer; 1981; 2(4):224-31. PubMed ID: 6810318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biotransformation of gentian violet to leucogentian violet by human, rat, and chicken intestinal microflora.
    McDonald JJ; Cerniglia CE
    Drug Metab Dispos; 1984; 12(3):330-6. PubMed ID: 6145560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes in the microflora of the large intestine in rats administered cephalexin and erythromycin orally].
    Lapchinskaia AV; Shenderov BA; Chakhava OV; Gorskaia EM
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):206-10. PubMed ID: 3579249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.